Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Papillomavirus Infections 1HIV Infections 1Cervical Cancer Screening 1Breast Neoplasms 1

Interventions

pembrolizumab 1268Specimen Handling 871Carboplatin 831Magnetic Resonance Spectroscopy 805Cyclophosphamide 802Cisplatin 728Nivolumab 658Paclitaxel 630Radiotherapy 573Gemcitabine 571Biopsy 529Bevacizumab 476Dexamethasone 440fludarabine 406Docetaxel 378venetoclax 370Oxaliplatin 365Capecitabine 358Fluorouracil 355atezolizumab 344durvalumab 333Rituximab 332Doxorubicin 317Radiosurgery 309Pemetrexed 306Drug Therapy 302Ipilimumab 294Standard of Care 293Etoposide 284Radiation 281

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Coal Tar × 1 year × Clear all
NCT07538050 2026-05-28

SCALE AIM 2

The Cleveland Clinic

Phase NA Recruiting
1,000 enrolled
Gynecologic

Cervical Cancer Screening

NCT05012813 2026-03-09

Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer

OHSU Knight Cancer Institute

Phase NA Completed
28 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07225530 2026-02-25

(iSTAR)

Columbia University

Phase NA Recruiting
600 enrolled
Gynecologic

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡